Analysis of apoptosis signaling pathway in human cancer cells by codeinone, a synthetic derivative of codeine

Naoko Hitosugi1, Hiroshi Nagasaka, Hiroshi Sakagami

  • 1Department of Anesthesiology, Saitama Medical School, Department of Dental Pharmacology, Meikai University School of Dentistry, Saitama, Japan. nao-hito@rc4.so-net.ne.jp

Anticancer Research
|August 5, 2003
PubMed

Insights

Codeinone, a codeine metabolite, effectively induces apoptosis in human cancer cells by activating the intrinsic mitochondrial pathway. This finding supports codeinone

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Codeinone, an oxidation metabolite of codeine, has shown potential in inducing apoptosis.
  • Previous studies indicated its effectiveness in HL-60 leukemic cells.

Purpose of the Study:

  • To investigate codeinone's apoptosis-inducing effects in various human cancer cell lines.
  • To explore codeinone's impact on mitochondrial enzymes and apoptotic signaling pathways.

Main Methods:

  • Flow cytometry (FACS) analysis for apoptotic cell detection.
  • Hoechst staining for microscopic visualization of apoptosis.
  • Fluorometric assays for caspase activation (caspase 3, 9, and 8).
  • Western blot analysis for apoptosis-related protein expression (Bax, Bcl-2, MnSOD).

Main Results:

  • Codeinone induced apoptosis in HL-60, MCF7, and A549 cancer cell lines.
  • Activation of caspase 3 and caspase 9, but not caspase 8, indicated intrinsic pathway involvement.
  • Codeinone modulated Bax and Bcl-2 protein expression, favoring apoptosis.
  • Manganese superoxide dismutase (MnSOD) activity and mRNA expression remained unchanged.

Conclusions:

  • Codeinone effectively induces apoptosis in diverse human cancer cells via the intrinsic mitochondrial pathway.
  • The observed apoptosis-inducing and antinociceptive activities highlight codeinone's potential as an antitumor agent.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...